EPO Patents = 1

Trademarks = 1

Forward Citations = 13

Loading Chart...

3 inventors (with patents filed for the assignee):

Scott Shandler (6 out of 6 patents)

Samuel Helmer Gellman (6 out of 57 patents)

John M Gledhill (3 out of 3 patents)

6 patents: Sort by Forward Citations

1. 11278595 - Peptides comprising non-natural amino acids and methods of making and using the same (2022-03-22),

2. 10772934 - Highly active polypeptides and methods of making and using the same (2020-09-15),

3. 10543255 - Peptides comprising non-natural amino acids and methods of making and using the same (2020-01-28),

4. 9790262 - Compositions comprising glucagon analogs and methods of making and using the same (2017-10-17),

5. 9789164 - Peptides comprising non-natural amino acids and methods of making and using the same (2017-10-17),

6. 9782454 - Highly active polypeptides and methods of making and using the same (2017-10-10),

Company Overview

Longevity Biotech, Inc. is a biotechnology company focused on developing novel therapeutics for aging-related diseases. Their proprietary platform technology enables the design and development of innovative drug candidates with increased stability and efficacy. With a strong pipeline of potential treatments, Longevity Biotech is committed to improving the quality of life for aging populations worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#146 in Philadelphia, PA

#1,623 in Pennsylvania

#44,981 in US

Philadelphia, PA, United States of America

Longevity Biotech, Inc.

Forward Citations = 13

3 inventors:

Scott Shandler (6 out of 6 patents)

Samuel Helmer Gellman (6 out of 57 patents)

John M Gledhill (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Longevity Biotech, Inc.. Retrieved from https://idiyas.com/company/longevity-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]